Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CHPA Petitions For Acetaminophen Under-2 Dose Labeling

This article was originally published in The Tan Sheet

Executive Summary

CHPA urges FDA not to wait until it publishes the final internal analgesics, antipyretic and anti-rheumatic monograph before allowing manufacturers to label acetaminophen products with dosing information for children 6 months to 2 years old. In a citizen petition, the trade group proposes FDA publish a statement of enforcement policy expressly permitting the use of a standardized age- and weigh-based dosing chart.

Advertisement

Related Content

“No End In Sight” For Completing OTC Monographs – CDER Director Woodcock
“No End In Sight” For Completing OTC Monographs – CDER Director Woodcock
CHPA Agenda 2014: Monograph Reform, NSURE Progress
CHPA Agenda 2014: Monograph Reform, NSURE Progress
Perrigo Recalls Infant Acetaminophen Liquid With Blank Dosing Syringe
Flow Restrictors Limit Children’s Access To Drugs; Standards Needed
Campaign Targets Unsupervised Pediatric Drug Ingestion
Pediatric Acetaminophen Panel Debates Execution Of Dosing Changes
OTC Industry Standardizes Pediatric Liquid Acetaminophen Concentration
Pediatric Acetaminophen Expanded Dosing Requested In McNeil Petition

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS106556

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel